We proved we can also win on penalties. We dealt with that,

We proved we can also win on penalties. We dealt with that,

I think they just wrestled hard. The guys who won, the guys who lost, every single one of them wrestled read more

I think they just wrestled hard. The guys who won, the guys who lost, every single one of them wrestled tough. Windsor is a well-coached team. We knew they were going to come in and just get after us. In order to prevent that, we've got to make sure we're even more prepared.

These oil companies are making profit hand over fist as consumers are suffering.

These oil companies are making profit hand over fist as consumers are suffering.

I feel like Canada's punishment from the US is over. They realize they've been choking our economy and with the read more

I feel like Canada's punishment from the US is over. They realize they've been choking our economy and with the new leader in Canada they're going to cut us some slack. People from the US are going to realize for the first time where Ottawa is and that it's the Capital of Canada.

It was OK. But Courtney messed it up. Our free throw shooting definitely carried us.

It was OK. But Courtney messed it up. Our free throw shooting definitely carried us.

We're back to 10 percent.

We're back to 10 percent.

He's been very helpful and accommodating, and I like coming to a local business,

He's been very helpful and accommodating, and I like coming to a local business,

It's not clear that the Fed is going to move in June. Perhaps, the Fed moves late summer/early fall, if read more

It's not clear that the Fed is going to move in June. Perhaps, the Fed moves late summer/early fall, if even then. What is clear is that the economy's momentum, which was quite strong in the first quarter, is indeed slowing down It is also clear that profit momentum for the year is going to be slow.

[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, read more

[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, after a slow start, it grew to become a $US2.3 billion ($3 billion today) blockbuster for its owner, Pfizer, in 2003.] About 80 per cent of the prescriptions were for unapproved uses - conditions like bipolar disorder, post-traumatic stress disorder, insomnia, restless legs syndrome, hot flashes, migraines and tension headaches, ... In fact, Neurontin has become a sort of all-purpose restorative for chronic discomfort of almost any type - yet there is almost no good published evidence that it works.